BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25583220)

  • 1. In vivo evaluation of a new ¹⁸F-labeled PET ligand, [¹⁸F]FEBU, for the imaging of I₂-imidazoline receptors.
    Kawamura K; Shimoda Y; Kumata K; Fujinaga M; Yui J; Yamasaki T; Xie L; Hatori A; Wakizaka H; Kurihara Y; Ogawa M; Nengaki N; Zhang MR
    Nucl Med Biol; 2015 Apr; 42(4):406-12. PubMed ID: 25583220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A useful PET probe [
    Kawamura K; Shimoda Y; Yui J; Zhang Y; Yamasaki T; Wakizaka H; Hatori A; Xie L; Kumata K; Fujinaga M; Ogawa M; Kurihara Y; Nengaki N; Zhang MR
    Nucl Med Biol; 2017 Feb; 45():1-7. PubMed ID: 27835825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of I2-imidazoline receptors by small-animal PET using 2-(3-fluoro-[4-11C]tolyl)-4,5-dihydro-1H-imidazole ([11C]FTIMD).
    Kawamura K; Naganawa M; Konno F; Yui J; Wakizaka H; Yamasaki T; Yanamoto K; Hatori A; Takei M; Yoshida Y; Sakaguchi K; Fukumura T; Kimura Y; Zhang MR
    Nucl Med Biol; 2010 Jul; 37(5):625-35. PubMed ID: 20610167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of PET probes for the imaging of I2 imidazoline receptors in peripheral tissues.
    Kawamura K; Yui J; Konno F; Yamasaki T; Hatori A; Wakizaka H; Fujinaga M; Kumata K; Yoshida Y; Ogawa M; Nengaki N; Yanamoto K; Fukumura T; Zhang MR
    Nucl Med Biol; 2012 Jan; 39(1):89-99. PubMed ID: 21831654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in the Binding of [
    Kawamura K; Yamasaki T; Zhang Y; Wakizaka H; Hatori A; Xie L; Fujinaga M; Zhang MR
    Mol Imaging Biol; 2019 Feb; 21(1):105-112. PubMed ID: 29736564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging imidazoline-I2 binding sites in porcine brain using 11C-BU99008.
    Kealey S; Turner EM; Husbands SM; Salinas CA; Jakobsen S; Tyacke RJ; Nutt DJ; Parker CA; Gee AD
    J Nucl Med; 2013 Jan; 54(1):139-44. PubMed ID: 23223380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET study using [11C]FTIMD with ultra-high specific activity to evaluate I2-imidazoline receptors binding in rat brains.
    Kawamura K; Kimura Y; Yui J; Wakizaka H; Yamasaki T; Hatori A; Kumata K; Fujinaga M; Yoshida Y; Ogawa M; Nengaki N; Fukumura T; Zhang MR
    Nucl Med Biol; 2012 Feb; 39(2):199-206. PubMed ID: 21958848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro imaging of I₂ imidazoline receptors in the monkey brain.
    Kawamura K; Maeda J; Hatori A; Okauchi T; Nagai Y; Higuchi M; Suhara T; Fukumura T; Zhang MR
    Synapse; 2011 May; 65(5):452-5. PubMed ID: 21370281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of fluorine-18-labeled SA4503 as a selective sigma1 receptor ligand for positron emission tomography.
    Kawamura K; Tsukada H; Shiba K; Tsuji C; Harada N; Kimura Y; Ishiwata K
    Nucl Med Biol; 2007 Jul; 34(5):571-7. PubMed ID: 17591557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180.
    Chau WF; Black AM; Clarke A; Durrant C; Gausemel I; Khan I; Mantzilas D; Oulie I; Rogstad A; Trigg W; Jones PA
    Nucl Med Biol; 2015 Sep; 42(9):711-9. PubMed ID: 26072270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorine-18 labeled diphenyl sulfide derivatives for imaging serotonin transporter (SERT) in the brain.
    Zhang Y; Liu F; Xiao H; Yao X; Li G; Choi SR; Ploessl K; Zha Z; Zhu L; Kung HF
    Nucl Med Biol; 2018 Nov; 66():1-9. PubMed ID: 30096380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new PET imaging agent [11C]AFE is a selective serotonin transporter ligand with fast brain uptake kinetics.
    Zhu Z; Guo N; Narendran R; Erritzoe D; Ekelund J; Hwang DR; Bae SA; Laruelle M; Huang Y
    Nucl Med Biol; 2004 Nov; 31(8):983-94. PubMed ID: 15607480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and initial in vitro and ex vivo characterization of the potential positron emission tomography ligand, BU99008 (2-(4,5-dihydro-1H-imidazol-2-yl)-1- methyl-1H-indole), for the imidazoline₂ binding site.
    Tyacke RJ; Fisher A; Robinson ES; Grundt P; Turner EM; Husbands SM; Hudson AL; Parker CA; Nutt DJ
    Synapse; 2012 Jun; 66(6):542-51. PubMed ID: 22290740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a new radioligand, N-(5-fluoro-2-phenoxyphenyl)-N-(2-[18F]fluoroethyl-5-methoxybenzyl)acetamide, for pet imaging of peripheral benzodiazepine receptor in primate brain.
    Zhang MR; Maeda J; Ogawa M; Noguchi J; Ito T; Yoshida Y; Okauchi T; Obayashi S; Suhara T; Suzuki K
    J Med Chem; 2004 Apr; 47(9):2228-35. PubMed ID: 15084121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of
    Tyacke RJ; Myers JFM; Venkataraman A; Mick I; Turton S; Passchier J; Husbands SM; Rabiner EA; Gunn RN; Murphy PS; Parker CA; Nutt DJ
    J Nucl Med; 2018 Oct; 59(10):1597-1602. PubMed ID: 29523627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of 11C-BU99008, a PET ligand for the imidazoline2 binding sites in rhesus brain.
    Parker CA; Nabulsi N; Holden D; Lin SF; Cass T; Labaree D; Kealey S; Gee AD; Husbands SM; Quelch D; Carson RE; Nutt DJ; Huang Y; Tyacke RJ
    J Nucl Med; 2014 May; 55(5):838-44. PubMed ID: 24711648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing new PET tracers to image the growth hormone secretagogue receptor 1a (GHS-R1a).
    Kawamura K; Fujinaga M; Shimoda Y; Yamasaki T; Zhang Y; Hatori A; Xie L; Wakizaka H; Kumata K; Ohkubo T; Kurihara Y; Ogawa M; Nengaki N; Zhang MR
    Nucl Med Biol; 2017 Sep; 52():49-56. PubMed ID: 28628775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vivo evaluation of novel PET radioligands for imaging the endothelin-A receptor.
    Mathews WB; Murugesan N; Xia J; Scheffel U; Hilton J; Ravert HT; Dannals RF; Szabo Z
    J Nucl Med; 2008 Sep; 49(9):1529-36. PubMed ID: 18703610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and 18F-labeling of the analogues of Omecamtiv Mecarbil as a potential cardiac myosin imaging agent with PET.
    Zhang M; Mou T; Zhao Z; Peng C; Ma Y; Fang W; Zhang X
    Nucl Med Biol; 2013 Jul; 40(5):689-96. PubMed ID: 23566883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facile Preparation of a Thiol-Reactive (18)F-Labeling Agent and Synthesis of (18)F-DEG-VS-NT for PET Imaging of a Neurotensin Receptor-Positive Tumor.
    Wu Z; Li L; Liu S; Yakushijin F; Yakushijin K; Horne D; Conti PS; Li Z; Kandeel F; Shively JE
    J Nucl Med; 2014 Jul; 55(7):1178-84. PubMed ID: 24854793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.